Business Review
-
11:50 Apr 04, 2022
German multinational pharma company Bayer is set to drive breakthrough innovations in Life Sciences through an investment worth more than EUR 1.3 billion over the next three years in its impact investment unit Leaps by Bayer, focusing on leading pharmaceutical technology platforms such as Cell & Gene Therapy to deliver solutions to patients in areas […]